Products for Research Use Only
RegisterLogin

Nadecnemab

CAT: 0804-HY-P99748-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99748-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1].
CAS Number
2377679-19-9
UNSPSC
12352203
Target
TGF-β Receptor
Type
Inhibitory Antibodies
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nadecnemab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Nadecnemab]
Molecular Weight
(144.86 kDa)
References & Citations
[1]Nadecnemab. Drugbank.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
abx831658-01Nadecnemab
GTR18337672-01Nadecnemab Antibody
HT009016-01Research Grade Nadecnemab
C00280-1mgNadecnemab (Anti-GFRA3)
047954GFRA3 (nadecnemab) discontinued
E55B0804Nadecnemab (Reference antibody)
F2029-50Anti-GFRA3 Antibody (Nadecnemab)
21-936Nadecnemab - Research Grade Biosimilar
GTR18780728-01(Nadecnemab) Biosimilar Reference Antibody
GTR18697351-01Nadecnemab Human Monoclonal Antibody

Popular Products